Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease

References

• Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004; 364:533–544.
   PubMed Web of Science ®Google Scholar
• Burns JC. The riddle of Kawasaki disease. N Engl J Med. 2007; 356:659–661.
   Google Scholar
• Brugner D, Davila S, Breunis WB, Ng SB, Bonnard C, Ling L, Wright VJ, Thalamuthu A, Odam M, Shimizu C, Burns JC, Levin M, Kuijpers TW, Hibberd ML. A genomic wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet. 2009; 5:e1000319.
   Google Scholar
• Burns JC, Shimizu C, Shike H, Newburger JW, Sundel RP, Baker AL, Matsubara T, Ishikawa Y, Brophy VA, Cheng S, Grow MA, Steiner LL, Kono N, Cantor RM. Family-based association analysis implicates IL-4 in susceptibility of Kawasaki disease. Genes Immun. 2005; 6:438–444.
   Google Scholar
• Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis. 2005; 192:344–349.
   Google Scholar
• Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Nakamura Y, Hata A. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008; 40:35–42.
   PubMed Web of Science ®Google Scholar
• Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001; 184:940–943.
   PubMed Web of Science ®Google Scholar
• Franco A, Albani S. Translating the concept of suppressor/regulatory T cells to clinical applications. Inter Rev Immunol. 2006; 25:27–47.
   Web of Science ®Google Scholar
• Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and to alloantigens in humans. Nat Rev. 2007; 7:585–598.
   Google Scholar
• Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001; 2:301–306.
   PubMed Web of Science ®Google Scholar
• Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigens. Nat Immunol. 2002; 3:756–763.
   PubMed Web of Science ®Google Scholar
• Walker LSK, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med. 2008; 198:249–258.
   Google Scholar
• Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen WJ. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol. 2008; 9:632–640.
   PubMed Web of Science ®Google Scholar
• Chen WJ, Jin W, Hardegen N, Lei K, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-ß induction of transcription factor Foxp3. J Exp Med. 2003; 198:1875–1886.
   PubMed Web of Science ®Google Scholar
• Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig M, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005; 6:1–9.
   PubMedGoogle Scholar
• Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol. 2003; 3:756–763.
   Google Scholar
• Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subset of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401:708–712.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol. 2004; 22:745–763.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Baggiolini M. Chemokines and leukocyte traffic. Nat Immunol. 2008; 9:949–952.
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA. Diagnosis, treatment and long term management of Kawaski disease: A statement for helath professionals from the Committee for Rheumatic Fever, Endocarditis and Kawaski Disease, Council on Cardiovascular Diseases in the Young, American Heart Association. Circulation. 2004; 110:2747–2771.
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007; 8:549–551.
   Google Scholar
• Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007; 8:942–949.
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol. 2005; 16:82–89.
   Google Scholar
• Apostolou I, von Boemer H. In vivo instruction od suppressor committment in naive T cells. J Exp Med. 2004; 199:1401–1408.
   PubMed Web of Science ®Google Scholar
• Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, Bastian J, Beiser AS, Meyerson HM, Newburger JW. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991; 118:680–686.
   PubMed Web of Science ®Google Scholar
• Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease—cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol. 2008; 6:394–401.
   PubMedGoogle Scholar
• Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, Crawford SE, Russo PA, Hammadeh R, Takahashi K, Orenstein JM. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE. 2008; 2:e1582.
   Google Scholar
• Faruno K, Yuge T, Kasuhara K, Takada H, Nishio H, Khajoee V, Ohno T, Hara T. CD25+CD4+ regulatory T cells in patients with Kawaski disease. J Pediat. 2004; 145:385.
   Google Scholar
• Trinchieri G. Interleukin-10 production by effector cells: Th1 cells show self control. J Exper Med. 2007; 204:239–243.
   PubMed Web of Science ®Google Scholar
• O'Garra A, Vieira P. Th1 cells control themselves by producing IL-10. Nat Rev. 2007; 7:425–428.
   Google Scholar
• Anderson CF, Oukka M, Kuchroo VJ, Sacks D. CD4+ CD25-Foxp3-Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med. 2007; 204:285–297.
   PubMed Web of Science ®Google Scholar
• Nylen S, Radheshyam M, Eidsmo L, Das Manandhar K, Sundar S, Sacks D. Splenic accumulation of Il-10 mRNA in T cells disinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med. 2007; 204:805–817.
   PubMed Web of Science ®Google Scholar
• Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, Wilson M, Wynn TA, Kamanaka M, Flavell FA, Sher A. Conventional T-bet+ Foxp3- Th1 cells are the major source of host protective regulatory IL10-during intracellular protozoan infection. J Exp Med. 2007; 204:273–283.
   PubMed Web of Science ®Google Scholar